Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Four Exchange-Traded Products Trading Higher Than Their Indicative Values


After the stunning decline in the TVIX Thursday, you may be wondering: Which exchange-traded product could be next? Here are four possibilities.


Admit it. You watched the stunning decline decline in the VelocityShares Daily 2x VIX Short-Term ETN (TVIX) on Thursday and wondered: Which exchange-traded product could be next? That's just human nature, and there's nothing wrong with wondering what ETF or ETN could be the next victim of a seriously skewed net asset value situation.

While a plunging ETN doesn't necessarily signal credit risk for the issuing bank (in this case Credit Suisse (CS)), ETNs trading at rich premiums to their indicative values could indeed be vulnerable to a potential TVIX sequel.

Credit Suisse is trying to ameliorate the situation with TVIX by allowing new share issuance. Only time will tell if that gambit works. In the meantime, there are other ETNs (and at least one ETF) out there that are either trading at levels that are a tad high relative to their indicative values or that have reputations for having done so in the past.

Take a look at this potentially notorious group.

1. VelocityShares 2x Long Copper ETN (LCPR) Ever hear of the VelocityShares 2x Long Copper ETN? We didn't think so. Apparently, a lot of folks haven't because it doesn't look like the ETN has traded since March 16.

LCPR, which made its debut last month, is designed "to provide long exposure to two times (2x) the daily performance of the S&P GSCI Copper Index ER (the "Index") plus a daily accrual equal to the return that could be earned on a notional capital reinvestment at the three month US Treasury rate as reported on Bloomberg under ticker USB3MTA, less the daily investor fee," according to the fund's product page.

Given the light volume, LCPR's 6.5% premium to its NAV may not be a big concern, but if the ETN's volume rapidly increased and the premium to NAV spiked, well, that might not be good.

2. UBS E-TRACS 1Mo S&P 500 VIX Futures ETN (VXAA) Another one that isn't going to win any ETN volume contests (less than 1,000 shares per day), VXAA could be viewed as controversial just for having "VIX" in its name. As of this writing, the ETN's indicative value for March 22 had not been updated, but as of March 21 the market closing price was roughly 10% higher than the indicative value.

3. iPath DJ-UBS Natural Gas TR Sub-Index ETN (GAZ) In the essence of simplicity, this what the situation is with GAZ. It closed at $4.90 on Thursday. It had an indicative value of $2.44 on Thursday. GAZ has over $37 million in AUM, 15.3 million shares outstanding, and strong average daily volume. See where we're going with this? There is a potential problem here.

4. Market Vectors China ETF (PEK) We noted there could be an ETF on this list and it comes in the form of the Market Vectors China ETF. Of the products on this list, PEK's tendency to trade above NAV is probably the least concerning situation. The ETF is the only option US investors have for getting exposure to China's A Shares market and to accomplish that aim, PEK uses swaps and derivatives. The demand for A Shares access and the use of derivatives may be the contributing factors to PEK's tendency to trade above its NAV.

Since its inception, PEK has regularly traded at a premium, which has generally ranged from 2% to 10%, according to Thursday'closing price: $35.93. Thursday's NAV: $33.09.

Editor's Note: This content was originally published on by The ETF Professor.

Below, find some more great ETF and market content from Benzinga:

By Brett Callwood
By Sam Mattera
By Lear Yann

Twitter: @Benzinga

Get your free trial here. Keep up on economic news as it happens with Benzinga Pro – get your free trial here.

< Previous
  • 1
Next >
No positions in stocks mentioned.

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.

Featured Videos